|Other Accession||Q498C7, Q91VT8, NP_777581.1|
|Other Names||Small integral membrane protein 14, SMIM14, C4orf34|
|Target/Specificity||The synthetic peptide sequence is selected from aa 71-84 of HUMAN SMIM14|
|Format||Synthetic peptide was lyophilized with 100% acetonitrile and is supplied as a powder. Reconstitute with 0.1 ml DI water for a final concentration of 1 mg/ml.|
|Storage||Maintain refrigerated at 2-8°C for up to 6 months. For long term storage store at -20°C.|
|Precautions||This product is for research use only. Not for use in diagnostic or therapeutic procedures.|
|Cellular Location||Endoplasmic reticulum membrane; Single-pass membrane protein EMBL; BC008502; AAH08502.1; -; mRNA CCDS; CCDS3456.1; - RefSeq; NP_001304825.1; NM_001317896.1 RefSeq; NP_001304826.1; NM_001317897.1 RefSeq; NP_777581.1; NM_174921.2 RefSeq; XP_016863351.1; XM_017007862.1 RefSeq; XP_016863352.1; XM_017007863.1 UniGene; Hs.205952; - UniGene; Hs.576320; - ProteinModelPortal; Q96QK8; - BioGrid; 128406; 3 IntAct; Q96QK8; 2 STRING; 9606.ENSP00000295958; - iPTMnet; Q96QK8; - PhosphoSitePlus; Q96QK8; - BioMuta; SMIM14; - DMDM; 74732680; - PaxDb; Q96QK8; - PeptideAtlas; Q96QK8; - PRIDE; Q96QK8; - DNASU; 201895; - Ensembl; ENST00000295958; ENSP00000295958; ENSG00000163683 GeneID; 201895; - KEGG; hsa:201895; - UCSC; uc003guo.4; human CTD; 201895; - GeneCards; SMIM14; - HGNC; HGNC:27321; SMIM14 HPA; HPA051299; - neXtProt; NX_Q96QK8; - OpenTargets; ENSG00000163683; - PharmGKB; PA162379760; - eggNOG; ENOG410J29M; Eukaryota eggNOG; ENOG41127PU; LUCA GeneTree; ENSGT00390000018294; - HOGENOM; HOG000037369; - HOVERGEN; HBG057647; - InParanoid; Q96QK8; - OMA; SVTMILM; - OrthoDB; EOG091G10PJ; - PhylomeDB; Q96QK8; - TreeFam; TF314023; - BioCyc; ZFISH:ENSG00000163683-MONOMER; - GenomeRNAi; 201895; - PRO; PR:Q96QK8; - Proteomes; UP000005640; Chromosome 4 Bgee; ENSG00000163683; - CleanEx; HS_C4orf34; - ExpressionAtlas; Q96QK8; baseline and differential Genevisible; Q96QK8; HS GO; GO:0005783; C:endoplasmic reticulum; IDA:UniProtKB GO; GO:0005789; C:endoplasmic reticulum membrane; IEA:UniProtKB-SubCell GO; GO:0016021; C:integral component of membrane; IEA:UniProtKB-KW InterPro; IPR020309; Uncharacterised_CD034/YQF4 Pfam; PF11027; DUF2615; 1 ProDom; PD288703; Uncharacterised_CD034/YQF4; 1 1: Evidence at protein level; Complete proteome; Endoplasmic reticulum; Membrane; Reference proteome; Transmembrane; Transmembrane helix CHAIN 1 99 Small integral membrane protein 14 /FTId=PRO_0000268816 TOPO_DOM 1 49 Lumenal. TRANSMEM 50 70 Helical. TOPO_DOM 71 99 Cytoplasmic. MUTAGEN 26 27 LR->TN: In N-gly,N; creates a N- glycosylation site MUTAGEN 76 77 RG->TN: In N-gly,C; does not creates a N- glycosylation site SEQUENCE 99 AA; 10710 MW; B0E90C424D2D34EB CRC64; MAEGGFDPCE CVCSHEHAMR RLINLLRQSQ SYCTDTECLQ ELPGPSGDNG ISVTMILVAW MVIALILFLL RPPNLRGSSL PGKPTSPHNG QDPPAPPVD|
Thousands of laboratories across the world have published research that depended on the performance of antibodies from Abgent to advance their research. Check out links to articles that cite our products in major peer-reviewed journals, organized by research category.
email@example.com, and receive a free "I Love Antibodies" mug.
Provided below are standard protocols that you may find useful for product applications.
Lehner, B., et al. Genome Res. 14(7):1315-1323(2004)
If you have used an Abgent product and would like to share how it has performed, please click on the "Submit Review" button and provide the requested information. Our staff will examine and post your review and contact you if needed.
If you have any additional inquiries please email technical services at firstname.lastname@example.org.